Jiying Zhou

2PUBLICATIONS
8CO-AUTHORS
Characterisation of biological macromoleculesTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 18, 2026
Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON study.

|Nov 20, 2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.

Shengyuan Yu, Byung-Kun Kim, Hebo Wang

Pageof 1

Frequent Collaborators

2 joint publications

Shengyuan Yu

2 joint publications

Byung-Kun Kim

2 joint publications

Hebo Wang

2 joint publications

Zheng Li